POMPANO BEACH, FL / November 6, 2023 / BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release its third quarter 2023 financial results pre-market on Tuesday, November 14, 2023.
BioStem will host a conference call and webcast at 10:30am ET on Tuesday, November 14, 2023. The call will include a discussion of third quarter 2023 financial results and a corporate update.
The live call can be accessed by dialing 1-877-317-6789 (domestic) or 1-412-317-6789 (international).
The live and archived webcast of the call will also be available on the BioStem Technologies website under the Investors section or by following this link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=h6fk2xLz.
